These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 2532102)
1. Patterns of hyperinsulinaemia in type 1 diabetic patients with and without nephropathy. Pickup JC; Collins AC; Walker JD; Viberti GC; Pasic J Diabet Med; 1989 Nov; 6(8):685-91. PubMed ID: 2532102 [TBL] [Abstract][Full Text] [Related]
2. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion. Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726 [TBL] [Abstract][Full Text] [Related]
3. Free insulin profiles during intensive treatment with biosynthetic human insulin. Olsson PO; Arnqvist HJ; Von Schenck HV Diabete Metab; 1988; 14(3):253-8. PubMed ID: 3044863 [TBL] [Abstract][Full Text] [Related]
4. Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII. Scheen AJ; Henrivaux P; Jandrain B; Paolisso G; Lefèbvre PJ Diabetes Care; 1987; 10(5):567-72. PubMed ID: 3315513 [TBL] [Abstract][Full Text] [Related]
5. Urinary insulin excretion rate: an index of free insulinaemia in insulin-dependent diabetics. Pickup JC; Collins AC; Keen H Diabet Med; 1984 Nov; 1(4):291-4. PubMed ID: 6242819 [TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy. Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006 [TBL] [Abstract][Full Text] [Related]
7. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies. Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887 [TBL] [Abstract][Full Text] [Related]
8. Abnormal growth hormone levels in insulin-dependent diabetic patients under continuous subcutaneous insulin infusion and intensified conventional treatment. Arias P; Kerner W; de la Fuente A; Pfeiffer EF Acta Endocrinol (Copenh); 1984 Oct; 107(2):250-5. PubMed ID: 6388208 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies. Olsson PO Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018 [TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051 [TBL] [Abstract][Full Text] [Related]
12. Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria. Bending JJ; Viberti GC; Bilous RW; Keen H Diabetes; 1985 Aug; 34 Suppl 3():69-73. PubMed ID: 4018422 [TBL] [Abstract][Full Text] [Related]
13. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy. Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052 [TBL] [Abstract][Full Text] [Related]
14. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus]. Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370 [TBL] [Abstract][Full Text] [Related]
15. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Ganes T; Kierulf P; Smeland E; Sandvik L; Aagenaes O Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1195-9. PubMed ID: 3096429 [TBL] [Abstract][Full Text] [Related]
16. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem? Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569 [TBL] [Abstract][Full Text] [Related]
17. Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients. Rave K; Heise T; Pfützner A; Heinemann L; Sawicki PT Diabetes Care; 2001 May; 24(5):886-90. PubMed ID: 11347749 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting. Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467 [TBL] [Abstract][Full Text] [Related]
19. Unbound and transthyretin-bound retinol-binding protein in serum and urine from diabetic patients with nephropathy and proteinuria. Holm J; Hemmingsen L Clin Chem; 1990 Nov; 36(11):1993-4. PubMed ID: 2242589 [No Abstract] [Full Text] [Related]